Chem. J. Chinese Universities ›› 2025, Vol. 46 ›› Issue (10): 20250121.doi: 10.7503/cjcu20250121

• Chemical Biology • Previous Articles     Next Articles

Chemical Enzymatic Analysis of Temporal Alterations in Mitochondrial Protein O-GlcNAc Modification during the Therapeutic Senescence Process of Breast Cancer Cells

JIANG Xinya1, MA Qile2, CHENG Hongying3, LIU Yin3, HUANG Huang2,4, ZHAO Ran2, LIU Yubo2(), ZHONG Xiaomin1,3()   

  1. 1.Department of Oncology,the First Affiliated Hospital of Huai’an,Nanjing Medical University,Huai’an 223000,China
    2.Department of Life Sciences and Pharmacy,Dalian University of Technology,Panjin 124000,China
    3.Department of Oncology,Huai’an Clinical College Affiliated to Xuzhou Medical University,Huai’an 223000,China
    4.Postdoctoral Workstation of Dalian Hissen Bio Pharm,Inc. ,Dalian 116620,China
  • Received:2025-04-23 Online:2025-10-10 Published:2025-05-23
  • Contact: ZHONG Xiaomin E-mail:liuyubo@dlut.edu.cn;13912074971@163.com
  • Supported by:
    the Science and Technology Development Fund of the Affiliated Hospital of Xuzhou Medical University, China(XYFZ202204);the Jiangsu Postgraduate Practice Innovation Program, China(SJCX24_1559)

Abstract:

Cellular premature senescence is closely related to mitochondrial dysfunction. In this study, doxorubicin was used to induce breast cancer cells MCF-7 to establish a model of therapeutic premature senescence cells. The chemical enzymatic method based on GalT1 enzyme(Y289L) was employed to label the mitochondrial O-GlcNAc glycoproteome of MCF-7 cells at multiple time points during the premature senescence process. Click chemistry reaction was utilized to orthogonally capture mitochondrial glycoproteins. Label-free quantitative proteomics analysis was carried out through LC-MS/MS to investigate the temporal quantitative changes of mitochondrial O-GlcNAc glycoproteins during the cellular premature senescence process. Moreover, the biological function enrichment analysis was conducted to identify mitochondrial O-GlcNAc modified proteins involved in the regulation of premature senescence of breast cancer cells, and to elucidate the mechanism by which mitochondrial O-GlcNAc glycosylation regulates cellular premature senescence.

Key words: Chemoenzymatic labelling method, Cell senescence, O-GlcNAcylation, Proteomics

CLC Number: 

TrendMD: